By Marie In TreatmentsPosted 7 December 2020 Positive clinical results from MOMENTUM Sarepta Therapeutics announces positive clinical results from MOMENTUM, a phase 2 clinical trial of SRP-5051 in patients with Duchenne muscular dystrophy amenable to skipping exon 51. Original [...]